Applying Pharmacodynamics and Antimicrobial Stewardship to Pediatric Preseptal and Orbital Cellulitis
- 14 October 2019
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pediatric Drugs
- Vol. 21 (6), 427-438
- https://doi.org/10.1007/s40272-019-00357-3
Abstract
Orbital and preseptal cellulitis are most commonly caused by organisms that originate in the upper respiratory tract or from the skin. There is significant variation in antibiotics used, but ampicillin–sulbactam, ceftriaxone, metronidazole, clindamycin, amoxicillin, amoxicillin–clavulanate, cefuroxime, and vancomycin are often used in the treatment of these infections. The choice of antibiotic, however, is only one consideration. It is also important that antibiotics are dosed to optimize their pharmacodynamic target attainment. Like other serious infections, therapy can be transitioned from initial intravenous therapy to an oral regimen when there are clear signs of clinical and laboratory improvement. The total duration of therapy for these infections have also been decreasing in recent years with durations of approximately 2 weeks becoming more common, even for orbital or subperiosteal infections. Antimicrobial stewardship programs can work closely with providers who manage these infections to create pathways, choose optimal antibiotics and dosage, transition from intravenous to oral therapy, and provide shortest effective durations.This publication has 49 references indexed in Scilit:
- Improved Vancomycin Dosing in Children Using Area Under the Curve ExposureThe Pediatric Infectious Disease Journal, 2013
- Therapeutic Equivalence Requires Pharmaceutical, Pharmacokinetic, and Pharmacodynamic Identities: True Bioequivalence of a Generic Product of Intravenous MetronidazoleAntimicrobial Agents and Chemotherapy, 2012
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsClinical Infectious Diseases, 2009
- Inpatient preseptal cellulitis: experience from a tertiary eye care centreBritish Journal of Ophthalmology, 2008
- Our experience using primary oral antibiotics in the management of orbital cellulitis in a tertiary referral centreEye, 2008
- Pharmacodynamic Target Attainment of Oral β-Lactams for the Empiric Treatment of Acute Otitis Media in ChildrenPediatric Drugs, 2008
- Cefdinir Pharmacokinetics and Tolerability in Children Receiving 25 mg/kg Once DailyThe Pediatric Infectious Disease Journal, 2006
- Pharmacokinetics and Pharmacodynamics of the Nitroimidazole AntimicrobialsClinical Pharmacokinetics, 1999
- Clinical pharmacokinetics of amoxicillin and clavulanateThe Pediatric Infectious Disease Journal, 1996
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995